4-Chloro-4-methylaminorex 4C-MAR 4-Cl-4-MAR

CAS NO: 13389
Description Review
Description
Introduction:
4-Chloro-4-methylaminorex (4C-MAR) emerges as a compound that is fascinating in the realm of synthetic stimulants due to its distinct chemical properties and potential applications. 4C-MAR, a structurally similar psychostimulant to 4-methylaminorex, merits careful study by chemists and pharmacologists due to its distinctive profile.

Chemical Composition:
4-Chloro-5-(4-chlorophenyl)-4-methyl-2,5-dihydro-1,3-oxazol-2-amine is the chemical name.
C11H12Cl2N2O Molecular Formula Formula Weight: 273.13 g/mol
CAS Number: Not Assigned (according to the most recent data available)
Some of the most common terms used to describe 4C-MAR in online databases and search engines are: stimulant, synthetic, research chemical, psychostimulant, designer drug, 4-MAR analogue, chlorinated aminorex, recreational use, neurological research, and substance control. Because of its relative newness and limited lexical resources, equivalents for 4C-MAR are hard to come by.
Products similar to Compete:
In terms of its stimulant effects, 4C-MAR is closely related to other stimulants such as 4-Methylaminorex (4-MAR), Methamphetamine, and MDMA. Nevertheless, its distinctive pattern of substitution sets it apart from these more prevalent counterparts.
Health Advantages:
No health benefits of 4C-MAR are officially recognized. Because it is classified as a research chemical, it is only used in scientific studies and not for human consumption.
Possible Consequences: In accordance with its structural resemblance to additional stimulants, 4C-MAR could potentially induce euphoria, heightened vitality, and improved cognitive performance. These effects, however, are speculative and have not been scientifically validated.
Product Mechanism: 4C-MAR is thought to work by releasing dopamine and norepinephrine in the central nervous system. This assumption is based on the structural similarity of the compound to known stimulants.
Safety and Side Effects: The safety profile of 4C-MAR is unknown. In the same way that many research chemicals can be abused, this substance can have harmful effects, such as neurotoxicity, cardiovascular risks, and psychological dependence.
Dosage Information Due to the fact that 4C-MAR is a research compound rather than a pharmaceutical product, there is no standard dosing information available for it. This substance should only be used for analytical and research purposes in a controlled laboratory setting.
Due to the lack of clinical data, individuals who suffer from cardiovascular, psychiatric, or neurological conditions shouldn't take 4C-MAR because it shouldn't be used in these patient populations. It is not intended for use by humans or animals.
In conclusion, much of the profile of 4-chloro-4-methylaminorex (4C-MAR) is shrouded in scientific uncertainty, making it a mysterious chemical of the research world. In spite of the fact that its potential is comparable to that of other stimulants, it is still a substance that should be approached with extreme caution because there are neither extensive studies nor well-established safety information available. To elucidate 4C-MAR's properties and potential applications or implications in the future, the scientific community must employ rigorous research methodologies.
Warning: this article presents a hypothetical synthesis based on the chemical structure and profiles of previously studied compounds. Because there is a paucity of actual data on 4C-MAR, the author of this article does not support or encourage the use of this substance in settings other than those designated for controlled research.

Substituted aminorex family
New psychoactive substances (NPS)
Halogenated 4-methylaminorex derivatives


To what extent does 4C-MAR have legal standing? The legal status of 4C-MAR differs depending on the nation and jurisdiction. Because of its propensity for misuse and its resemblance to other illegal stimulants, it is often classified as a restricted drug in many countries. It is often included on the same list as several other synthetic substances that fall within the purview of the laws governing narcotics. It is always best to check the local laws to see if something is allowed. What are the effects of 4C-MAR on the human body? As a central nervous system stimulant, 4C-MAR may boost alertness, focus, and energy. It may also increase your heart rate, blood pressure, and cause you to feel euphoric. On the other hand, because of its strength, it has the potential to have major harmful consequences on one's health, including the development of an addiction, damage to the nervous system, and other problems. Is 4C-MAR suitable for medical applications? Currently, 4C-MAR is not licensed for medical therapy owing to inadequate studies on its effectiveness and safety for therapeutic usage. Although it has been investigated in the context of neurochemistry and pharmacology, the primary reason for its interest is not for therapeutic applications but rather for research objectives. What are the potential dangers linked to 4C-MAR? In addition to a variety of health complications, 4C-MAR carries the possibility of abuse and addiction. Serious adverse effects, including heart issues, anxiety, psychosis, and cognitive decline, may result from using it. Given its potency and limited research on long-term effects, the substance is widely regarded as high-risk. What methods are used to detect 4C-MAR in the laboratory? Lab tests like gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) can use advanced methods to find 4C-MAR. These techniques are highly effective in determining the presence and amount of 4C-MAR in biological samples or chemical preparations, making them crucial for forensic analysis and research studies.
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code